Clinical trial
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant…
NCT00102934 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Unknown status
Key facts
| NCT number | NCT00102934 |
|---|---|
| Title | Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus |
| Official title | Treatment Intensification in HIV-1 Patients With Multi-Drug Resistant Virus |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Enfuvirtide-intensified HAART |
| Enrollment | 20 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Mar 1, 2009 |
| First posted | Feb 7, 2005 |
| Last update posted | Sep 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: